ATE165240T1 - Natriuretisches hormon - Google Patents
Natriuretisches hormonInfo
- Publication number
- ATE165240T1 ATE165240T1 AT89908739T AT89908739T ATE165240T1 AT E165240 T1 ATE165240 T1 AT E165240T1 AT 89908739 T AT89908739 T AT 89908739T AT 89908739 T AT89908739 T AT 89908739T AT E165240 T1 ATE165240 T1 AT E165240T1
- Authority
- AT
- Austria
- Prior art keywords
- compound
- natriuretic
- natriuretic hormone
- hormone
- c21h28o5
- Prior art date
Links
- 239000002934 diuretic Substances 0.000 title abstract 5
- 230000001452 natriuretic effect Effects 0.000 title abstract 4
- 229940088597 hormone Drugs 0.000 title abstract 2
- 239000005556 hormone Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 4
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001882 diuretic effect Effects 0.000 abstract 1
- 208000019622 heart disease Diseases 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000003637 steroidlike Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Confectionery (AREA)
- Fertilizers (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21745888A | 1988-07-11 | 1988-07-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE165240T1 true ATE165240T1 (de) | 1998-05-15 |
Family
ID=22811166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89908739T ATE165240T1 (de) | 1988-07-11 | 1989-07-10 | Natriuretisches hormon |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0429480B1 (de) |
| JP (1) | JP2954248B2 (de) |
| AT (1) | ATE165240T1 (de) |
| CA (1) | CA1332734C (de) |
| DE (1) | DE68928646T2 (de) |
| WO (1) | WO1990000394A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE80225T1 (de) * | 1989-05-23 | 1992-09-15 | Biosensors Technology Inc | Verfahren zur bestimmung mittels strahlungsabsorption von substanzen in absorbierenden und streuenden matrixmaterialien. |
| US5178142A (en) * | 1989-05-23 | 1993-01-12 | Vivascan Corporation | Electromagnetic method and apparatus to measure constituents of human or animal tissue |
| US5183042A (en) * | 1989-05-23 | 1993-02-02 | Vivascan Corporation | Electromagnetic method and apparatus to measure constituents of human or animal tissue |
| US5277181A (en) * | 1991-12-12 | 1994-01-11 | Vivascan Corporation | Noninvasive measurement of hematocrit and hemoglobin content by differential optical analysis |
| US6525022B1 (en) | 1993-11-12 | 2003-02-25 | Genentech, Inc. | Receptor specific atrial natriuretic peptides |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3445933A1 (de) * | 1984-12-17 | 1986-06-19 | Röhm GmbH, 6100 Darmstadt | Arzneimittel mit diuretischer wirksamkeit |
-
1989
- 1989-07-10 AT AT89908739T patent/ATE165240T1/de not_active IP Right Cessation
- 1989-07-10 JP JP1508219A patent/JP2954248B2/ja not_active Expired - Fee Related
- 1989-07-10 EP EP89908739A patent/EP0429480B1/de not_active Expired - Lifetime
- 1989-07-10 WO PCT/US1989/002987 patent/WO1990000394A1/en not_active Ceased
- 1989-07-10 DE DE68928646T patent/DE68928646T2/de not_active Expired - Fee Related
- 1989-07-11 CA CA000605306A patent/CA1332734C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE68928646D1 (de) | 1998-05-28 |
| JP2954248B2 (ja) | 1999-09-27 |
| EP0429480A1 (de) | 1991-06-05 |
| CA1332734C (en) | 1994-10-25 |
| DE68928646T2 (de) | 1998-08-13 |
| JPH04500957A (ja) | 1992-02-20 |
| EP0429480A4 (de) | 1994-01-05 |
| EP0429480B1 (de) | 1998-04-22 |
| WO1990000394A1 (en) | 1990-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2075219T3 (es) | Metodos y composiciones para curar ulceras. | |
| LU90951I2 (fr) | Eurifel rcp felv et ses dérivés pharmaceutiquement acceptables | |
| DK630789A (da) | Anvendelse af nalmefen eller naltrexon til fremstilling af et laegemiddel til behandling af autoimmune sygdomme | |
| DE69219607D1 (de) | Verfahren zur anregung der immunresponz | |
| FI80906B (fi) | Foerfarande foer extraktion av intakt rekombinant-human-immuninterferonprotein. | |
| ES2143132T3 (es) | Monohidratos de derivado de acido aminobenceno-sulfonico y su metodo de preparacion. | |
| ATE214698T1 (de) | Neue carbamazepin hapten analoge | |
| LU88790I2 (fr) | Moxidectin et ses dérivés pharmaceutiquement acceptables | |
| FI842457A0 (fi) | 1-alkyl-androsta-1,4-dien-3,17-dioner, deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska produkter. | |
| IT8149156A0 (it) | Procedimento per la produzione dell'ormone gonadotropo dell'ipofi si anteriore | |
| ATE165240T1 (de) | Natriuretisches hormon | |
| SE8204873L (sv) | Farmaceutiska preparat, innefattande humant insulin och human c-peptid | |
| SE7708678L (sv) | Proteinhormoner | |
| ATE208042T1 (de) | Hapten-analoge zur verwendung in immunoassays | |
| FI900145L (fi) | Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi | |
| EP0353474A3 (de) | Glyzerin-Derivat und dessen pharmazeutische Verwendung | |
| FI894812A0 (fi) | Menetelmä valmistaa farmakologisesti arvokkaita 2-karbonyylisubstituoituja N,N'-di(trimetoksibentsoyyli)piperatsiineja | |
| FI890678A7 (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi | |
| ATE95422T1 (de) | Ein synthetisches nonapeptid zur verwendung als adjuvant. | |
| DK146785A (da) | Pharmaceutisk praeparat med indhold af 9alfa, 11beta-dichlor-16alfa-methyl-21-oxycarbonyldicyclohexylmethyloxypregna-1,4-dien-3,20-dion | |
| DE3780105D1 (de) | 13alpha-alkylgonan-delta9(11)-5,10-epoxide. | |
| ES2104551T3 (es) | Analogos terapeuticos de somatostatina. | |
| SE8204872L (sv) | Farmaceutiska preparat, innefattande humant insulin, human c-peptid och humant proinsulin | |
| IT8821135A0 (it) | Derivato dell'acido ursodesossicolico. | |
| ATE111489T1 (de) | Derivate und analoge von monoethylglycinxylidid und ihre herstellung und anwendung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |